Wednesday, March 05, 2025 | 09:42 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Gujarat sees a surge in small drug firms eyeing regulated export venues

Traditionally, small and medium players had focused on the semi-regulated markets such as Latin America and Africa, among others

The company already enjoys a 67-68 per cent share of the respiratory drugs market in India and has potential for a 14-15 per cent growth
Premium

The company already enjoys a 67-68 per cent share of the respiratory drugs market in India and has potential for a 14-15 per cent growth

Vinay Umarji Ahmedabad
The country’s pharma hub Gujarat has, of late, witnessed a surge in small-sized drug firms eyeing regulated markets like the US and Europe for exports. Traditionally, small and medium players had focused on the semi-regulated markets such as Latin America and Africa, among others. 

However, with big pharma firms focusing on specialty drugs in the US market, owing to pricing pressure in plain vanilla generics, the smaller players have seen an opportunity in this space, partially vacated by the large ones.

The pharma industry in Gujarat is buzzing again with new entrants that are eyeing aggressively the regulated markets of the United

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in